These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2942201)
1. Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell lines. Kano Y; Ohnuma T; Holland JF Blood; 1986 Aug; 68(2):586-91. PubMed ID: 2942201 [TBL] [Abstract][Full Text] [Related]
2. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939 [TBL] [Abstract][Full Text] [Related]
4. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
5. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
6. A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717). Takemura Y; Ohnuma T; Miyachi H; Sekiguchi S J Cancer Res Clin Oncol; 1991; 117(6):519-25. PubMed ID: 1683871 [TBL] [Abstract][Full Text] [Related]
7. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Dixon KH; Trepel JB; Eng SC; Cowan KH Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001 [TBL] [Abstract][Full Text] [Related]
8. Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cells. Rodenhuis S; McGuire JJ; Sawicki WL; Bertino JR Leukemia; 1987 Feb; 1(2):116-20. PubMed ID: 2959824 [TBL] [Abstract][Full Text] [Related]
9. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues. Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines. Mini E; Moroson BA; Franco CT; Bertino JR Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284 [TBL] [Abstract][Full Text] [Related]
11. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477 [TBL] [Abstract][Full Text] [Related]
12. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Rhee MS; Galivan J; Wright JE; Rosowsky A Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264 [TBL] [Abstract][Full Text] [Related]
13. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro. Kamen BA; Eibl B; Cashmore A; Bertino J Biochem Pharmacol; 1984 May; 33(10):1697-9. PubMed ID: 6233981 [No Abstract] [Full Text] [Related]
14. Biological activity and intracellular metabolism of ZD1694 in human leukemia cell lines with different resistance mechanisms to antifolate drugs. Takemura Y; Kobayashi H; Miyachi H; Gibson W; Kimbell R; Jackman AL Jpn J Cancer Res; 1996 Jul; 87(7):773-80. PubMed ID: 8698629 [TBL] [Abstract][Full Text] [Related]
15. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line. Gong M; Yess J; Connolly T; Ivy SP; Ohnuma T; Cowan KH; Moscow JA Blood; 1997 Apr; 89(7):2494-9. PubMed ID: 9116294 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
18. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates. Kobayashi H; Takemura Y; Ohnuma T Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake. van der Veer LJ; Westerhof GR; Rijksen G; Schornagel JH; Jansen G Leuk Res; 1989; 13(11):981-7. PubMed ID: 2532692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]